Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL19664202 | 1.00 | CA4 (0.55) | — | |
| Bicarbonate SCHEMBL7713688 | 0.95 | CA4 (0.50) | — | |
| Bicarbonate SCHEMBL3395196 | 0.95 | CA4 (0.50) | — | |
| Bicarbonate SCHEMBL15666483 | 0.95 | CA4 (0.50) | — | |
| Bicarbonate SCHEMBL28340034 | 0.95 | — | — | |
| Bicarbonate SCHEMBL1332486 | 0.94 | — | — | |
| Bicarbonate SCHEMBL83 | 0.94 | — | — | |
| Bicarbonate SCHEMBL1332636 | 0.94 | — | — | |
| Bicarbonate SCHEMBL15321596 | 0.94 | CA4 (0.60) | — | |
| Bicarbonate SCHEMBL5403678 | 0.94 | CA4 (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116859046-A | Helicobacter pylori detects card | 深圳市康乃格生物技术有限公司 | 2023-10-10 | — | — | CN | claimed |
| US-11638912-B2 | Metal catalyst synthesis and acid/metal bifunctional catalyst systems thereof | ExxonMobil Technology and Engineering Company (US) | 2023-05-02 | — | — | US | claimed |
| US-20210046460-A1 | METAL CATALYST SYNTHESIS AND ACID/METAL BIFUNCTIONAL CATALYST SYSTEMS THEREOF | EXXONMOBIL RES & ENG CO (US) | 2021-02-18 | — | — | US | claimed |
| CN-103084523-B | High intensity U bolt processing method | 芜湖市创源新材料有限公司 | 2016-08-03 | — | — | CN | claimed |
| CN-103084523-A | Method for machining high-strength U-shaped bolt | ANHUI LIUFANG ZHONGLIAN MECHANICAL SHARE CO LTD | 2013-05-08 | — | — | CN | claimed |
| WO-2007064105-A1 | NOVEL PROCESS FOR PREPARATION OF 2,6-DIALKYLNAPHTHALENE | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2007-06-07 | — | — | WO | claimed |
| US-20260092038-A1 | CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOF | CORBUS PHARMACEUTICALS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-12553022-B2 | Processes for converting biomass into high-value products | TEXAS A & M UNIV SYS (US) | 2026-02-17 | — | — | US | disclosed |
| US-20260027275-A1 | DIALYSIS KITS FOR PREPARING DIALYSIS FLUIDS AND RELATED SYSTEMS AND RELATED METHODS | MOZARC MEDICAL US LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-20250276967-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES | SIGNAL PHARMACEUTICALS, LLC | 2025-09-04 | — | — | US | disclosed |
| US-20250248973-A1 | CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOF | CORBUS PHARMACEUTICALS, INC. | 2025-08-07 | — | — | US | disclosed |
| US-12338235-B2 | Heterocyclic compounds and their use for treatment of helminthic infections and diseases | CELGENE CORPORATION (US) | 2025-06-24 | — | — | US | disclosed |
| WO-2025078629-A1 | CAPSULE FOR DELIVERY OF A CARRIER SYSTEM WITH A LOCALLY ACTING CARGO TO THE INTESTINES OF A MAMMAL | ENTEROTARGET APS (DK) | 2025-04-17 | — | — | WO | disclosed |
| EP-0135351-A1 | Manufacturing process for N-carbobenzyloxy-L-glutamic acid-alpha-cholinester salt | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 1985-03-27 | — | — | EP | disclosed |
| EP-0025598-B1 | THE USE OF 2-PHENYLTETRALIN DERIVATIVES, OR HETEROCYCLIC ANALOGUES, IN MEDICINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | THE WELLCOME FOUNDATION LIMITED (GB) | 1984-08-01 | — | — | EP | disclosed |
| EP-0084837-A1 | Flocculation of latex particles and production of thermoplastic resin | MITSUBISHI KASEI POLYTEC COMPANY (JP) | 1983-08-03 | — | — | EP | disclosed |
| EP-0081971-A2 | Novel cephalosporin compound and process for preparing the same | Tanabe Seiyaku Co., Ltd. (JP) | 1983-06-22 | — | — | EP | disclosed |
| EP-0001089-B1 | PROCESS FOR THE PREPARATION OF HALOGENOVINYL-SUBSTITUTED 2-TETRAHYDROFURANONES, SELECTED HALOGENOVINYL-SUBSTITUTED 2-TETRAHYDROFURANONES | BAYER AG (DE) | 1981-10-21 | — | — | EP | disclosed |
| EP-0025598-A1 | The use of 2-phenyltetralin derivatives, or heterocyclic analogues, in medicine and pharmaceutical compositions containing them | THE WELLCOME FOUNDATION LIMITED (GB) | 1981-03-25 | — | — | EP | disclosed |
| EP-0001089-A1 | Process for the preparation of halogenovinyl-substituted 2-tetrahydrofuranones, selected halogenovinyl-substituted 2-tetrahydrofuranones | BAYER AG (DE) | 1979-03-21 | — | — | EP | disclosed |